Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Operating Leases (2019 - 2025)

Historic Operating Leases for Tandem Diabetes Care (TNDM) over the last 9 years, with Q3 2025 value amounting to $139.7 million.

  • Tandem Diabetes Care's Operating Leases rose 955.36% to $139.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.7 million, marking a year-over-year increase of 955.36%. This contributed to the annual value of $106.4 million for FY2024, which is 629.64% down from last year.
  • As of Q3 2025, Tandem Diabetes Care's Operating Leases stood at $139.7 million, which was up 955.36% from $139.9 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Operating Leases registered a high of $143.8 million during Q1 2025, and its lowest value of $23.9 million during Q4 2021.
  • Its 5-year average for Operating Leases is $111.1 million, with a median of $130.1 million in 2024.
  • As far as peak fluctuations go, Tandem Diabetes Care's Operating Leases soared by 41636.15% in 2022, and later tumbled by 805.67% in 2023.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Operating Leases stood at $23.9 million in 2021, then surged by 416.36% to $123.5 million in 2022, then dropped by 8.06% to $113.6 million in 2023, then decreased by 6.3% to $106.4 million in 2024, then soared by 31.27% to $139.7 million in 2025.
  • Its last three reported values are $139.7 million in Q3 2025, $139.9 million for Q2 2025, and $143.8 million during Q1 2025.